BJL
DGX icon

Brighton Jones LLC’s Quest Diagnostics DGX Stock Holding History

Brighton Jones LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Buy
2,160
+173
+9% +$34K 0.01% 828
2026
Q1 		$389K Buy
+1,987
New +$386K 0.01% 806
2025
Q4 		– Sell
-2,548
Closed -$486K – 270
2025
Q3 		$486K Buy
2,548
+19
+0.8% +$3.37K 0.01% 640
2025
Q2 		$454K Buy
2,529
+350
+16% +$60.8K 0.01% 572
2025
Q1 		$369K Buy
2,179
+35
+2% +$5.75K 0.01% 474
2024
Q4 		$323K Buy
+2,144
New +$333K 0.01% 499
2024
Q3 		– Sell
-1,760
Closed -$241K – 602
2024
Q2 		$241K Buy
1,760
+62
+4% +$8.49K 0.01% 523
2024
Q1 		$226K Buy
1,698
+4
+0.2% +$519 0.01% 540
2023
Q4 		$234K Buy
+1,694
New +$223K 0.01% 501
2023
Q3 		– Sell
-1,531
Closed -$215K – 553
2023
Q2 		$215K Sell
1,531
-42
-3% -$5.79K 0.01% 491
2023
Q1 		$223K Buy
1,573
+84
+6% +$12K 0.01% 447
2022
Q4 		$233K Buy
+1,489
New +$214K 0.01% 399
2022
Q1 		– Sell
-1,351
Closed -$234K – 522
2021
Q4 		$234K Buy
+1,351
New +$206K 0.01% 446
2021
Q2 		– Sell
-1,843
Closed -$237K – 484
2021
Q1 		$237K Buy
1,843
+15
+0.8% +$1.85K 0.01% 362
2020
Q4 		$218K Buy
1,828
+2
+0.1% +$244 0.01% 347
2020
Q3 		$209K Buy
+1,826
New +$216K 0.01% 309
2020
Q1 		– Sell
-1,954
Closed -$209K – 289
2019
Q4 		$209K Hold
1,954
– – 0.02% 301
2019
Q3 		$209K Sell
1,954
-37
-2% -$3.8K 0.02% 290
2019
Q2 		$203K Buy
+1,991
New +$191K 0.02% 289
2017
Q3 		– Sell
-2,016
Closed -$224K – 296
2017
Q2 		$224K Buy
+2,016
New +$213K 0.03% 244

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Brighton Jones LLC's DGX Position: Q2 2026 in Review

Brighton Jones LLC increased its Quest Diagnostics (DGX) stake by 8.7% in Q2 2026, buying an estimated $34K and bringing the position to 2,160 shares worth $458K. The position accounts for 0.01% of the portfolio, ranked #828.

Brighton Jones LLC first reported a position in DGX in Q2 2017 and has held it in 20 quarters since. The position peaked at $486K in Q3 2025. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Brighton Jones LLC held 2,160 shares of Quest Diagnostics worth $458K as of Q2 2026.
  • Brighton Jones LLC bought 173 Quest Diagnostics shares in Q2 2026, an estimated $34K.
  • Quest Diagnostics made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #828 holding.
  • Brighton Jones LLC first reported a position in Quest Diagnostics in Q2 2017 and has held it in 20 quarters since.
  • Brighton Jones LLC's Quest Diagnostics position peaked at $486K in Q3 2025.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.